Kangmei Pharmaceutical Co Ltd Capital Reinvestment Ratio
Kangmei Pharmaceutical Co Ltd capital reinvestment ratio. Kangmei Pharmaceutical Co Ltd (600518) has a Capital Reinvestment Ratio of 0.22x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥219.96 Million) in capital expenditures (CN¥48.57 Million). See 600518 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Kangmei Pharmaceutical Co Ltd (1999–2021)
Capital reinvestment ratio of Kangmei Pharmaceutical Co Ltd from 1999 to 2021. This chart tracks Kangmei Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 22 annual periods. See Kangmei Pharmaceutical Co Ltd (600518) flexibility index to measure the company's free cash flow as a share of total liabilities.
Kangmei Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (1999–2021)
Kangmei Pharmaceutical Co Ltd capital reinvestment ratio by year from 1999 to 2021. For the full cash flow conversion analysis, see how efficiently does Kangmei Pharmaceutical Co Ltd generate cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.80x | CN¥214.21 Million | CN¥171.63 Million | ▲ +173.9% |
| 2020 | 0.29x | CN¥1.03 Billion | CN¥301.73 Million | ▲ +78.2% |
| 2019 | 0.16x | CN¥2.88 Billion | CN¥473.20 Million | ▼ -98.9% |
| 2018 | 15.03x | CN¥305.62 Million | CN¥4.59 Billion | ▲ +1437.2% |
| 2016 | 0.98x | CN¥1.60 Billion | CN¥1.57 Billion | ▼ -63.8% |
| 2015 | 2.70x | CN¥508.86 Million | CN¥1.37 Billion | ▲ +348.5% |
| 2014 | 0.60x | CN¥1.13 Billion | CN¥682.06 Million | ▲ +43.4% |
| 2013 | 0.42x | CN¥1.67 Billion | CN¥703.43 Million | ▼ -69.8% |
| 2012 | 1.39x | CN¥1.01 Billion | CN¥1.41 Billion | ▼ -65.5% |
| 2011 | 4.04x | CN¥574.96 Million | CN¥2.32 Billion | ▲ +251.7% |
| 2010 | 1.15x | CN¥669.19 Million | CN¥768.02 Million | ▼ -81.1% |
| 2009 | 6.06x | CN¥119.47 Million | CN¥724.25 Million | ▼ -97.4% |
| 2008 | 229.90x | CN¥3.02 Million | CN¥693.14 Million | ▲ +11285.6% |
| 2007 | 2.02x | CN¥162.55 Million | CN¥328.23 Million | ▼ -66.6% |
| 2006 | 6.05x | CN¥68.32 Million | CN¥413.45 Million | ▲ +3496.3% |
| 2005 | 0.17x | CN¥133.13 Million | CN¥22.40 Million | ▼ -91.2% |
| 2004 | 1.91x | CN¥78.52 Million | CN¥150.20 Million | ▲ +206.9% |
| 2003 | 0.62x | CN¥78.02 Million | CN¥48.63 Million | ▼ -83.5% |
| 2002 | 3.79x | CN¥53.47 Million | CN¥202.41 Million | ▼ -49.0% |
| 2001 | 7.43x | CN¥15.69 Million | CN¥116.54 Million | ▲ +4442.5% |
| 2000 | 0.16x | CN¥9.96 Million | CN¥1.63 Million | ▼ -61.8% |
| 1999 | 0.43x | CN¥30.25 Million | CN¥12.96 Million | — |